Application: Use of unlabeled oligonucleotide probe system in molecular diagnostics.

被引：0
|
作者：
Chou, LS
Lyon, A
Meadows, C
Lyon, E
Wittwer, C
机构：
[1] ARUP Labs, Salt Lake City, UT USA
[2] Univ Utah, Salt Lake City, UT USA
来源：
CLINICAL CHEMISTRY | 2004年 / 50卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：2228 / 2228
页数：1
相关论文
共 50 条
  • [41] Study on Pharmacokinetics and acute toxicity of hTERT antisense oligonucleotide molecular probe
    Wang, R.
    Liu, M.
    Zhang, C.
    Yan, P.
    Yu, M.
    Cui, Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S355 - S355
  • [42] Intelligent Decision-Support System for Epidemiological Diagnostics. II. Information Technologies Development*, *
    Bazilevych, K. O.
    Chumachenko, D., I
    Hulianytskyi, L. F.
    Meniailov, I. S.
    Yakovlev, S., V
    CYBERNETICS AND SYSTEMS ANALYSIS, 2022, 58 (04) : 499 - 509
  • [43] Intelligent Decision-Support System for Epidemiological Diagnostics. I. A Concept of Architecture Design
    K. O. Bazilevych
    D. I. Chumachenko
    L. F. Hulianytskyi
    I. S. Meniailov
    S. V. Yakovlev
    Cybernetics and Systems Analysis, 2022, 58 : 343 - 353
  • [44] Intelligent Decision-Support System for Epidemiological Diagnostics. II. Information Technologies Development*, **
    K. O. Bazilevych
    D. I. Chumachenko
    L. F. Hulianytskyi
    I. S. Meniailov
    S. V. Yakovlev
    Cybernetics and Systems Analysis, 2022, 58 : 499 - 509
  • [45] Intelligent Decision-Support System for Epidemiological Diagnostics. I. A Concept of Architecture Design
    Bazilevych, K. O.
    Chumachenko, D., I
    Hulianytskyi, L. F.
    Meniailov, I. S.
    Yakovlev, S., V
    CYBERNETICS AND SYSTEMS ANALYSIS, 2022, 58 (03) : 343 - 353
  • [46] Use of REMEDI analysis combined with liquid-chromatography/mass-spectroscopy in acute toxicological diagnostics.
    Schmid, RW
    Mitulovic, G
    CLINICAL CHEMISTRY, 2000, 46 (06) : A193 - A193
  • [47] Value of precision medicine in advanced NSCLC: Real-world outcomes associated with the use of companion diagnostics.
    John, Ani
    Shah, Roma
    Wong, William Bruce
    Schneider, Charles
    Gari, Hamid H.
    Johnson, Marliese
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [48] Accurate diagnostics with the use of molecular colonies
    Chetverin, AB
    Chetverina, HV
    MOLECULAR BIOLOGY, 2002, 36 (02) : 244 - 250
  • [49] The use of molecular diagnostics in bladder cancer
    Han, M
    Schoenberg, MP
    UROLOGIC ONCOLOGY, 2000, 5 (03): : 87 - 92
  • [50] Detection of clinically relevant gene fusions in plasma samples of lung cancer patients in routine molecular diagnostics.
    Streubel, Anna
    Mairinger, Thomas
    Kollmeier, Jens
    Stephan-Falkenau, Susann
    Blum, Torsten-Gerriet
    Misch, Daniel
    Volckmar, Anna-Lena
    Schirmacher, Peter
    Stenzinger, Albrecht
    Endris, Volker
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345